Tirzepatide, a recently approved medication, is generating considerable buzz within the scientific community. It works differently from traditional diabetes medications, targeting two receptors involved in sugar regulation and appetite . Initial research have demonstrated remarkable efficacy in reducing blood sugar in individuals with type 2 diabet